Studies in Adipose-Derived Stromal Cells: Migration and Participation in Repair of Cranial Injury after Systemic Injection

Division of Plastic and Reconstructive Surgery, Stanford University, Palo Alto, California, United States
Plastic and Reconstructive Surgery (Impact Factor: 2.99). 03/2011; 127(3):1130-40. DOI: 10.1097/PRS.0b013e3182043712
Source: PubMed


Adipose-derived stromal cells are a multipotent cell type with the ability to undergo osteogenic differentiation. The authors sought to examine whether systemically administered adipose-derived stromal cells would migrate to and heal surgically created defects of the mouse cranial skeleton.
Mouse adipose-derived stromal cells were harvested from luciferase-positive transgenic mice; human adipose-derived stromal cells were harvested from human lipoaspirate and labeled with luciferase and green fluorescent protein. A 4-mm calvarial defect (critical sized) was made in the mouse parietal bone; skin incisions alone were used as a control (n = 5 per group). Adipose-derived stromal cells were injected intravenously (200,000 cells per animal) and compared with saline injection only. Methods of analyses included micro-computed tomographic scanning, in vivo imaging system detection of luciferase activity, and standard histology.
Migration of adipose-derived stromal cells to calvarial defect sites was confirmed by accumulation of luciferase activity and green fluorescent protein stain as early as 4 days and persisting up to 4 weeks. Little activity was observed among control groups. Intravenous administration of either mouse or human adipose-derived stromal cells resulted in histologic evidence of bone formation within the defect site, in comparison with an absence of bone among control defects. By micro-computed tomographic analysis, human but not mouse adipose-derived stromal cells stimulated significant osseous healing.
Intravenously administered adipose-derived stromal cells migrate to sites of calvarial injury. Thereafter, intravenous human adipose-derived stromal cells contribute to bony calvarial repair. Intravenous administration of adipose-derived stromal cells may be an effective delivery method for future efforts in skeletal regeneration.

Download full-text


Available from: Aaron W James, Jan 05, 2014
13 Reads
  • Source
    • "ASC-based therapeutic strategies have been proposed for either regenerative or targeted therapies and often rely on native tropism of ASCs for wound healing, inflammation, or cancer. Although investigations of cell adhesion and migration in purified ACs are currently ongoing, much can be learned from the unfractionated ASCs which have been shown to home to sites of injury and promote tissue repair following systemic injections in animal models of myocardial infarction [128, 129], liver injury [130, 131], olfactory dysfunction [132], hypoxia-ischemia induced brain damage [133], allergic rhinitis [134], inflammatory neuropathy [135], sciatic crush [136], cranial injury [137], and muscular dystrophy [138, 139]. The migratory activity of early-passage ASCs can be modulated by a set of chemokines and growth factors, including PDGF-AB, TGF-β1, and TNFα [140]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mesenchymal stem/stromal cells (MSCs) and MSC-like multipotent stem/progenitor cells have been widely investigated for regenerative medicine and deemed promising in clinical applications. In order to further improve MSC-based stem cell therapeutics, it is important to understand the cellular kinetics and functional roles of MSCs in the dynamic regenerative processes. However, due to the heterogeneous nature of typical MSC cultures, their native identity and anatomical localization in the body have remained unclear, making it difficult to decipher the existence of distinct cell subsets within the MSC entity. Recent studies have shown that several blood-vessel-derived precursor cell populations, purified by flow cytometry from multiple human organs, give rise to bona fide MSCs, suggesting that the vasculature serves as a systemic reservoir of MSC-like stem/progenitor cells. Using individually purified MSC-like precursor cell subsets, we and other researchers have been able to investigate the differential phenotypes and regenerative capacities of these contributing cellular constituents in the MSC pool. In this review, we will discuss the identification and characterization of perivascular MSC precursors, including pericytes and adventitial cells, and focus on their cellular kinetics: cell adhesion, migration, engraftment, homing, and intercellular cross-talk during tissue repair and regeneration.
    Stem cell International 08/2013; 2013(6):983059. DOI:10.1155/2013/983059 · 2.81 Impact Factor
  • Source
    • "Given that cells from two different fat depots and two different individuals responded similarly to the AuNPs, the data support the notion that AuNPs suppress ADSC differentiation and limit their capacity for migration. AuNPs have effectively been used for drug delivery and cell tracking (Ricles et al. 2011; Lammers et al. 2011; Levi et al. 2011; Brown et al. 2010; Paciotti et al. 2006). Given their potential adverse effects, we evaluated cell " recovery " following growth in AuNP-free media. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Gold nanoparticles (AuNPs) are used in various fields; however, their potential health risk(s) are still under the question. In this manuscript, we describe the interactions of AuNPs with human adipose derived stromal cells (ADSCs) and show that they are able to penetrate cell membrane and are stored in vacuoles. As expected, it was found that the uptake of the AuNPs is a function of time, their size and concentration as well as culture media used. Our results show that differentiation process of the ADSCs is affected by the presence of AuNPs and lead to the suppression of the adipogenesis by down regulation of adipogenic protein adiponectin and lipid accumulation inhibition. We also found significantly bigger decrease in fibronectin production in all samples exposed to AuNPs during the differentiation process. No changes were observed in collagen production. ADSCs wound healing ability was also inhibited by AuNPs in terms of cell migration and collagen contraction. Lastly, we also present data that indicates that AuNPs damage to cells is not permanent and that the cells can completely recover as a function of AuNPs size, concentration and exposure time.
    Nanotoxicology 01/2013; 8(2). DOI:10.3109/17435390.2013.769128 · 6.41 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Studies have shown that adipose-derived stem cells may improve neovascularization, graft take, and much more. Many strategies have been developed in the last years to isolate and take advantage of these cells for different applications in many specialties. Immediate cell-supplemented lipotransfer (iCSL) is a reproducible and immediate approach that consists in isolating a great number of stem cells from the harvested fat and injecting the suspension with processed adipose tissue as a scaffold in the same procedure, in a short time and cost-effective manner. In this article, the authors present iCSL throughout its processing method, its advantages and current applications in plastic and reconstructive surgery, and its potential applications in all fields of regenerative medicine
    European Journal of Plastic Surgery 05/2011; 35(5). DOI:10.1007/s00238-011-0651-5
Show more